Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula 30 [hp_X]/1
Candida Albicans, Wood Creosote, Sodium Chloride, Sulphur · TABLET · TRP Company
Com-Pare2 Dual Yeast Relief Plus Multi-Symptom Formula is an over-the-counter oral tablet containing a non-standardized fungal allergenic extract intended to provide relief from yeast-related symptoms. This product is designed to address multiple symptoms associated with Candida albicans.
Key Facts
- Brand Name
- Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula
- Generic Name
- Candida Albicans, Wood Creosote, Sodium Chloride, Sulphur
- NDC Code (Product)
17312-477- Manufacturer
- TRP Company
- Strength
- 30 [hp_X]/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Drug Class
- Non-Standardized Fungal Allergenic Extract [EPC]
- Marketing Start
- 04/30/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula used for?
Com-Pare2 Dual Yeast Relief Plus Multi-Symptom Formula is an over-the-counter oral tablet containing a non-standardized fungal allergenic extract intended to provide relief from yeast-related symptoms. This product is designed to address multiple symptoms associated with Candida albicans.
Is Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula a controlled substance?
Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula is not classified as a controlled substance by the DEA.
What is the generic name for Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula?
The generic name for Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula is Candida Albicans, Wood Creosote, Sodium Chloride, Sulphur. There are no other listed brand versions of Candida Albicans, Wood Creosote, Sodium Chloride, Sulphur.
What is the NDC code for Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula 30 [hp_X]/1?
The NDC (National Drug Code) for Com-Pare2 Dual Yeast Relief Plus Multi-symptom Formula 30 [hp_X]/1 is 17312-477, listed by TRP Company.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)